Linea Mercati Interview 4/28/26

April 29, 2026

VIEW US growth picks up; PCE inflation is higher but in line with expectations

April 30, 2026

Alternus Clean Energy is a forward-thinking utility-scale clean energy independent power producer that effectively leverages transatlantic markets to amplify its impact and create value for shareholders. With a strategic focus on solar, battery storage and microgrids, Alternus has a robust portfolio and pipeline featuring operational and projects in development across America and Europe, backed by long-term power purchase agreements that ensure stable revenue streams.

Founded in 2015, Perfect Corp. is a beautiful AI Company and global leader in enterprise SaaS solutions. As an innovative powerhouse in using artificial intelligence (AI) to transform the beauty and fashion industries, Perfect empowers major beauty, skincare, fashion, jewelry brands and retailers by providing consumers with omnichannel shopping experiences through augmented reality (AR) product try-ons and AI-powered skin diagnostics. With cutting-edge technologies such as Generative AI, real-time facial and hand 3D AR rendering and cloud solutions, Perfect enables personalized, enjoyable, and engaging shopping journey.

In addition, Perfect also operates a family of YouCam consumer apps for photo, video and camera users, centered on unleashing creativity with AI-driven features for creation, beautification and enhancement. With the help of technologies, Perfect helps brands elevate customer engagement, increase conversion rates, and propel sales growth. Throughout this journey, Perfect maintains its unwavering commitment to environmental sustainability and fulfilling social responsibilities. For more information, visit https://ir.perfectcorp.com/.

Acurx Pharmaceuticals is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. The Company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram-positive specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin resistant Enterococcus (VRE) and drug-resistant Streptococcus pneumoniae (DRSP). To learn more about Acurx Pharmaceuticals and its product pipeline, please visit www.acurxpharma.com

Founded in 2010, AgEagle was originally formed to pioneer proprietary, professional-grade, fixed-winged drones and aerial imagery-based data collection and analytics solutions for the agriculture industry. Today, the Company is earning distinction as a globally respected market leader offering customer-centric, advanced, autonomous unmanned aerial systems ("UAS”) which drive revenue at the intersection of flight hardware, sensors and software for industries that include agriculture, military/defense, public safety, surveying/mapping and utilities/engineering, among others. AgEagle has also achieved numerous regulatory firsts, including earning governmental approvals for its commercial and tactical drones to fly Beyond Visual Line of Sight ("BVLOS”)and/or Operations Over People ("OOP”) in the United States, Canada, Braziland the European Union and being awarded Blue UAS certification from the Defense Innovation Unit of the U.S. Department of Defense.

BREAKTHROUGH ARTIFICIAL INTELLIGENCE. Our proprietary AI-technology will transform education by delivering dynamic, real-time and two-way human-like conversations with our AI-Super Teachers.

AI-POWERED SUPER TEACHERS: Imagine having a teacher available 24/7 who adapts to your learning style and offers instant feedback. Our AI-powered teachers make this into reality. Our algorithms and natural language processing provide personalized lessons, conversations, and offer real-time feedback to enrich your learning experience.

COMBINING PROFESSIONAL AND LANGUAGE SKILLS LEARNING; Professional skills and topics covered include hospitality, nursing, engineering, AI coding, computer science, social media marketing, high school exam prep, and much more.

CUSTOMIZED LEARNING PATHS AI algorithms analyze a learner's proficiency, learning style, strengths, weaknesses, and goals to create a tailor-made learning path. This ensures that the content is relevant to the individual.

A UNIQUE AI-POWERED EVALUATION SYSTEM This simulates real-life scenarios to provide the most meaningful performance assessment and proof of ability.

FROM A FINANCIAL PERSPECTIVE, THE POTENTIAL IS ENORMOUS Our platform meets specific training needs for career development across multiple industries, ensuring lucrative engagement and robust ROI. Sectors like coding and hospitality alone present giant market opportunities.

ALPHA COGNITION, INC is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative disease, such as Alzheimer’s disease and Cognitive Impairment with mild Tramautic Brain Injury (“mTBI”). The Company’s first product ZUNVEYL is approved by the U.S. Food and Drug Administration (FDA) as a cholinesterase inhibitor indicated for the treatment of mild to moderate dementia of the Alzheimer’s type in adults.

Launched in 2018, ALT5 Sigma Inc. (a wholly-owned subsidiary of ALT5 Sigma Corporation) is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Sigma Inc., through its subsidiaries, offers two main platforms to its customers: "

ALT5 Pay" and "ALT5 Prime". ALT5 Sigma Inc. processed over US$1.2 billion in cryptocurrency transactions in 2023. ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. Merchants have the option to convert to fiat currency (s) automatically or to receive their payment in digital assets.

ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named "ALT5 Pro" that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime's FIX API, as well as through Broadridge Financial Solutions' NYFIX gateway for approved customers.

CEL-SCI Corporation (NYSE American: CVM) is a biotechnology company that believes that boosting a cancer patient’s immune system before surgery, radiotherapy and chemotherapy, while it is still intact, should provide the greatest possible impact on survival.

Chromocell is a pioneer in the development of non-opioid pain treatment therapeutics with a focus on modulating NaV1.7 receptors responsible for sensing and transmitting pain in the peripheral nervous system. The Company’s programs targeting the treatment of chronic neuropathic and acute and chronic eye pain are based on its patented core molecules.

Focus Universal Inc. (NASDAQ:FCUV) is a provider of patented hardware and software design technologies for Internet of Things (IoT) and 5G. The company has developed five disruptive patented technology platforms with 28 patents and patents pending in various phases and 8 trademarks pending in various phases to solve the major problems facing hardware and software design and production within the industry today. These technologies combined to have the potential to reduce costs, product development timelines and energy usage while increasing range, speed, efficiency, and security. Focus currently trades on the Nasdaq Markets.

Greenland Technologies Holding Corp (NASDAQ: GTEC) is a leading developer and manufacturer of electric industrial vehicles and drivetrain systems for material handling vehicles.

Impact Biomedical Inc.(IBIO) discovers, confirms, and patents unique science and technologies which can be developed into new offerings in human healthcare and wellness in collaboration with external partners through licensing, co-development, joint ventures, and other relationships.

By leveraging technology and new science with strategic partnerships, we provide advances in biopharmaceuticals, over the counter direct to consumer wellness offerings, and drug discovery for the prevention, inhibition, and treatment of neurological, oncologic, and inflammatory diseases. In addition to our existing efforts, we continually search for, and evaluate, other potential new offerings to add to our portfolio.

Our business model includes partnering and potentially direct sales for commercialization and distribution. Potential licensors and development partners include pharmaceutical, consumer packaged goods companies and others, who would commercialize IBIO technologies in exchange for milestone, and royalty payments.

Lipella Pharmaceuticals (Nasdaq: LIPO) is a Pittsburgh-based clinical-stage biotechnology company focused on developing treatments for serious diseases with significant unmet needs. The company has a broad portfolio of three promising IND-approved assets and operates an in-house manufacturing facility. Lipella’s proprietary drug delivery platform utilizes liposomal formulations of tacrolimus, enabling localized treatment with minimal systemic exposure. The company is advancing two lead assets in Phase 2 clinical trials: LP-10, targeting hemorrhagic cystitis, and LP-310, an oral rinse for Oral Lichen Planus. Both programs leverage the 505(b)(2) regulatory pathway to expedite development and reduce costs.

Linea Mercati Interview 4/29/26

April 30, 2026

US Accuses Mexican Governor Moya Of Cartel Conspiracy, Sheinbaum Demands Evidence

April 30, 2026

By Reuters

April 30, 20269:30 AM EDTUpdated 8 mins ago

People walk through a shopping mall at The Venetian Las Vegas resort, in Las Vegas, Nevada, U.S., November 18, 2025. REUTERS/Daniel Cole/File Photo Purchase Licensing Rights, opens new tab

NEW YORK, April 30 (Reuters) – U.S. economic growth picked up in the first quarter on a rebound in government spending, but the increase is likely temporary as the drives up gasoline prices and squeezes household budgets.

Gross domestic product increased at a 2.0% annualized rate last quarter, the Commerce Department’s Bureau of Economic Analysis said in its advance GDP estimate on Thursday. Economists polled by Reuters had forecast GDP growth increasing at a 2.3% annualized rate. Much of the growth came from a partial reversal in government outlays.

Get a look at the day ahead in U.S. and global markets with the Morning Bid U.S. newsletter. Sign up here.

Advertisement · Scroll to continue

Meanwhile the U.S. Commerce Department said on Thursday its Personal Consumption Expenditures Price Index (PCE) rose in line with expectations in March, the latest sign that inflation remained relatively well behaved despite the war with Iran. March PCE rose 3.5% year over year, matching the consensus estimate, while rising 0.7% from February, also matching estimates. The core PCE price index, excluding volatile food and energy prices, rose 0.3% as expected.

MARKET REACTION:

STOCKS: U.S. major indexes were set to open higher, with futures tracking the Dow Jones Industrial Average (.DJI), opens new tab up 0.7%.

BONDS: Treasury securities rallied on Thursday morning, with the yields on the 2-year and 10-year Treasury notes falling. The 2-year note was down 6 basis points to 3.89% and the 10-year note was off 3 basis points to 4.38%.

Advertisement · Scroll to continue

FOREX: The dollar index was off 0.4% to 98.50.

COMMENTS:

PETER CARDILLO, CHIEF MARKET ECONOMIST, SPARTAN CAPITAL SECURITIES, NEW YORK:

“Well, 2.0% GDP was a rebound from the low growth rate in Q4, which was mostly due to the government shutdown. The first quarter suggests that we’re probably going to average 2.5% for the year, is solid growth, but certainly nothing that you can describe as extreme. It’s basically the average GDP growth that we’ve had for the past four to five years.

“Personal spending came in better than expected, and it shows that the consumer remains resilient. That’s subject to change, of course, if energy prices continue to rise.

“Headline and core year-on-year inflation above 3.2% is obviously a negative. And most of it, of course, is due to energy prices. For now, we can label it as transitory. However, if the war continues and energy prices do not come down from the present levels, that transitory inflation will become constant inflation and certainly a major headache for the Federal Reserve.”

MICHAEL LORIZIO, HEAD OF US RATES AND MORTGAGE TRADING AT MANULIFE INVESTMENT MANAGEMENT, BOSTON;

“The U.S. data this morning was mixed but probably validates the Fed’s stance yesterday of a little bit of a hawkish turn or a hawkish leaning compared to the previous meeting. I would not be leaning into any of the communication that a hike is in anyone’s immediate forecast, but some more balanced view and more just a commitment to looking at how the economic data comes in from here on out.

“Today was a big first step in that and seeing how measured inflation from their preferred measure looks and core PCE obviously being as expected, but materially higher than where the Fed would like to see it. It was already materially higher pre the conflict in Iran and this is just accelerating that.”

“On the flip side, jobless claims hitting such low levels and continuing claims hitting low levels… there’s reason for the Fed to continue to have concerns there, and this doesn’t take that away, but there’s no ammunition here for the Fed to continue to talk about near-term cuts. And that I think was the purpose of their change in messaging yesterday, or the dissenters’ push for a broader change in messaging.”

BRIAN JACOBSEN, CHIEF ECONOMIST, ANNEX WEALTH MANAGEMENT, MENOMONEE FALLS, WISCONSIN:

“High growth isn’t always healthy growth. Half a percentage point of GDP growth came from computers and another half from healthcare. It’s not a shaky foundation for growth, but not the most solid either.”

Reporting by Stephen Culp, Karen Brettell and Chuck Mikolajczak; editing by Colin Barr

Our Standards: The Thomson Reuters Trust Principles., opens new tab

US Accuses Mexican Governor Moya Of Cartel Conspiracy, Sheinbaum Demands Evidence

April 30, 2026

Bond yields fall, stocks rise as oil prices fall; yen jumps after Japan’s reported currency intervention

April 30, 2026

By Stephen Culp and Niket Nishant

April 30, 20265:26 AM EDTUpdated 37 mins ago

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 29, 2026. REUTERS/Brendan McDermid Purchase Licensing Rights, opens new tab

- Summary

- Companies

- Indexes up: Dow 1.51%, S&P 500 0.89% and Nasdaq 0.83%

- Alphabet rises after strong results

- Meta, Microsoft fall on capex concerns

- Eli Lilly gains after lifting forecast

NEW YORK, April 30 (Reuters) – U.S. stocks advanced on Thursday and the S&P 500 and the Nasdaq headed for their biggest monthly gains in years as solid corporate earnings helped investors look past a war-related oil supply shock that has rattled markets and sent crude prices to four-year highs.

But oil prices , eased as investors prepared to close the book on April with solid gains. The S&P 500 and the Nasdaq were on course for their biggest monthly percentage gains since the Covid crash recovery in 2020.

Industrials (.SPLRCI), opens new tab, powered by Caterpillar shares, put the Dow out front, while technology contained the Nasdaq’s gains in the wake of a spate of high-profile quarterly results released late Wednesday.

Four members of the Magnificent Seven group of artificial intelligence-related megacaps reported late Wednesday: Alphabet (GOOGL.O), opens new tab, Amazon (AMZN.O), opens new tab, Meta Platforms (META.O), opens new tab and Microsoft (MSFT.O), opens new tab. Of those, only Alphabet shares were in positive territory, jumping 9.7% after reporting a record quarter for its cloud unit.

Amazon was off 0.4%, while Meta and Microsoft slid 7.8% and 4.7%, respectively, on concerns over artificial intelligence-related expenditures.

Apple (AAPL.O), opens new tab, another Magnificent Seven constituent, was slated to report after the bell.

The Dow Jones Industrial Average (.DJI), opens new tab rose 738.90 points, or 1.51%, to 49,600.71, the S&P 500 (.SPX), opens new tab gained 63.31 points, or 0.89%, to 7,199.26 and the Nasdaq Composite (.IXIC), opens new tab gained 204.35 points, or 0.83%, to 24,878.32.

Of the 11 major sectors in the S&P 500, only technology (.SPLRCT), opens new tab was red, while communication services (.SPLRCL), opens new tab and industrials (.SPLRCI), opens new tab led the gainers.

CRUDE PRICES, INFLATION AND THE FED

A raft of economic data showed the U.S. economy grew by 2.0% in the first three months of 2026, while initial jobless claims dipped to their lowest since 1969 and soaring energy prices kept year-on-year inflation above 3%, thwarting hopes of near-term rate cuts from the Federal Reserve as Jerome Powell’s eight-year tenure as chair draws to a close.

“For now, we can label (inflation) as transitory,” said Peter Cardillo, chief market economist at Spartan Capital Securities in New York. “However, if the war continues and energy prices do not come down from the present levels, that transitory inflation will become constant inflation and certainly a major headache for the Federal Reserve.”

On Wednesday, in its most divided vote since 1992, the central bank let its key interest rate stand, while acknowledging uncertainties related to heightened crude prices due to the conflict in the Middle East.

That conflict showed no sign of abating, with Iran warning of retribution if the United States abandons its ceasefire and renews its attacks, suggesting that efforts to negotiate a peace deal have hit an impasse. Top U.S. military leaders were expected to brief President Donald Trump on potential military action in Iran, a U.S. official told Reuters.

The possibility of protracted war, long-term disruption of traffic in the Strait of Hormuz, and the prolonged pressure on energy prices have dampened hopes for near-term policy easing from monetary policymakers.

Inflation gauges

Eli Lilly (LLY.N), opens new tab gained 10.3% after the drugmaker raised its annual profit forecast on sustained weight-loss drug demand.

Caterpillar (CAT.N), opens new tab shares rose 10.1%, touching a record high following the company’s reported rise in first-quarter profit due to strong demand for its power generation and construction equipment.

Advancing issues outnumbered decliners by a 3.54-to-1 ratio on the NYSE. There were 281 new highs and 47 new lows on the NYSE.

On the Nasdaq, 3,408 stocks rose and 1,237 fell as advancing issues outnumbered decliners by a 2.76-to-1 ratio.

The S&P 500 posted 29 new 52-week highs and 15 new lows while the Nasdaq Composite recorded 99 new highs and 86 new lows.

Reporting by Niket Nishant and Utkarsh Hathi in Bengaluru; Editing by Devika Syamnath, Shinjini Ganguli and Aurora Ellis

Our Standards: The Thomson Reuters Trust Principles., opens new tab

S&P 500, Nasdaq set for biggest monthly gains since 2020

April 30, 2026

Linea Mercati Interview 4/30/26

May 4, 2026

By Caroline Valetkevitch and Marc Jones

April 29, 20269:56 PM EDTUpdated 1 hour ago

Item 1 of 2 Futures-options traders work on the floor at the New York Stock Exchange’s NYSE American (AMEX) in New York City, U.S., April 17, 2026. REUTERS/Brendan McDermid/File Photo

[1/2]Futures-options traders work on the floor at the New York Stock Exchange’s NYSE American (AMEX) in New York City, U.S., April 17, 2026. REUTERS/Brendan McDermid/File Photo Purchase Licensing Rights, opens new tab

- Summary

- Companies

- Brent tumbles after reaching a four-year high

- ECB and BoE both hold rates in Europe

- Global bond yields drop

- Apple results due later on Thursday on Wall Street

NEW YORK/LONDON, April 30 (Reuters) – Global bond yields fell and major stock indexes gained on Thursday as oil prices retreated from four-year highs, while the yen jumped after Japanese authorities were reported to have intervened in foreign exchange markets to support their currency.

U.S. crude fell 2.02% to $104.72 a barrel and Brent fell to $114.03 per barrel, down 3.39% on the day.

Iran said it would respond with “long and painful strikes” on U.S. positions if Washington renewed attacks, and also reasserted its control over the Strait of Hormuz, complicating U.S. plans for a coalition to reopen the waterway.

ECB and Bank of England kept rates steady. On Wednesday, there was a hawkish shift in tone from the Federal Reserve as it left rates on hold. Three of the U.S. central bank’s board members voted to drop the easing bias in its policy statement in the most divided decision since 1992.

“Yields are moving lower because the price of oil is coming down. That’s helping stocks, as well as some of the earnings reports that were good,” said Peter Cardillo, chief market economist at Spartan Capital Securities in New York.

Tech-related earnings were mostly strong, with shares of Alphabet (GOOGL.O), opens new tab up sharply following a for its cloud unit.

Earnings from iPhone maker Apple (AAPL.O), opens new tab are due after the closing bell.

The S&P 500 and the Nasdaq were on course to end April with their biggest gains since 2020.

The Dow Jones Industrial Average (.DJI), opens new tab rose 669.39 points, or 1.37%, to 49,530.40, the S&P 500 (.SPX), opens new tab rose 30.40 points, or 0.43%, to 7,166.35 and the Nasdaq Composite (.IXIC), opens new tab rose 12.65 points, or 0.05%, to 24,685.40.

MSCI’s gauge of stocks across the globe (.MIWD00000PUS), opens new tab rose 5.36 points, or 0.50%, to 1,072.92. The pan-European STOXX 600 (.STOXX), opens new tab index rose 1.38%.

The U.S. dollar fell sharply against the yen after Japanese authorities were reported to have intervened in foreign exchange markets to support their currency.

Officials had intervened to buy the yen, two sources familiar with the matter told Reuters, after it hit its weakest against the dollar since July 2024.

The dollar fell by as much as 3% against the yen to 155.5 yen, making for the largest single-day drop since late December 2024. It was last down 2.36% at 156.51 yen. Against the Japanese yen , the dollar was last down 2.38% at 156.57.

The yield on benchmark U.S. 10-year notes fell 1.8 basis points to 4.398%, from 4.416% late on Wednesday.

The 2-year UK gilt yields were back below 4.5%, while 2-year German yields – which are sensitive to near-term ECB rate changes – looked set to snap an eight-day run on gains.

The day’s earlier swing in oil prices was over 10 percentage points. Brent was last at $113.5 a barrel and down almost 4% having been as high as $126.41 overnight. It is still nearly double the price it started the year at.

On Wednesday, outgoing Chair Jerome Powell confirmed he would stay on as a governor for now to defend the institution’s independence as his successor Kevin Warsh, picked by low-rate advocate U.S. President Donald Trump, moves toward confirmation.

An arrow chart with the title ‘How interest rates have changed among G10 central banks’

Reporting by Caroline Valetkevitch and Marc Jones; editing by Timothy Heritage and Nick Zieminski

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Alternus Clean Energy is a forward-thinking utility-scale clean energy independent power producer that effectively leverages transatlantic markets to amplify its impact and create value for shareholders. With a strategic focus on solar, battery storage and microgrids, Alternus has a robust portfolio and pipeline featuring operational and projects in development across America and Europe, backed by long-term power purchase agreements that ensure stable revenue streams.

Founded in 2015, Perfect Corp. is a beautiful AI Company and global leader in enterprise SaaS solutions. As an innovative powerhouse in using artificial intelligence (AI) to transform the beauty and fashion industries, Perfect empowers major beauty, skincare, fashion, jewelry brands and retailers by providing consumers with omnichannel shopping experiences through augmented reality (AR) product try-ons and AI-powered skin diagnostics. With cutting-edge technologies such as Generative AI, real-time facial and hand 3D AR rendering and cloud solutions, Perfect enables personalized, enjoyable, and engaging shopping journey.

In addition, Perfect also operates a family of YouCam consumer apps for photo, video and camera users, centered on unleashing creativity with AI-driven features for creation, beautification and enhancement. With the help of technologies, Perfect helps brands elevate customer engagement, increase conversion rates, and propel sales growth. Throughout this journey, Perfect maintains its unwavering commitment to environmental sustainability and fulfilling social responsibilities. For more information, visit https://ir.perfectcorp.com/.

Acurx Pharmaceuticals is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. The Company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram-positive specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin resistant Enterococcus (VRE) and drug-resistant Streptococcus pneumoniae (DRSP). To learn more about Acurx Pharmaceuticals and its product pipeline, please visit www.acurxpharma.com

Founded in 2010, AgEagle was originally formed to pioneer proprietary, professional-grade, fixed-winged drones and aerial imagery-based data collection and analytics solutions for the agriculture industry. Today, the Company is earning distinction as a globally respected market leader offering customer-centric, advanced, autonomous unmanned aerial systems ("UAS”) which drive revenue at the intersection of flight hardware, sensors and software for industries that include agriculture, military/defense, public safety, surveying/mapping and utilities/engineering, among others. AgEagle has also achieved numerous regulatory firsts, including earning governmental approvals for its commercial and tactical drones to fly Beyond Visual Line of Sight ("BVLOS”)and/or Operations Over People ("OOP”) in the United States, Canada, Braziland the European Union and being awarded Blue UAS certification from the Defense Innovation Unit of the U.S. Department of Defense.

BREAKTHROUGH ARTIFICIAL INTELLIGENCE. Our proprietary AI-technology will transform education by delivering dynamic, real-time and two-way human-like conversations with our AI-Super Teachers.

AI-POWERED SUPER TEACHERS: Imagine having a teacher available 24/7 who adapts to your learning style and offers instant feedback. Our AI-powered teachers make this into reality. Our algorithms and natural language processing provide personalized lessons, conversations, and offer real-time feedback to enrich your learning experience.

COMBINING PROFESSIONAL AND LANGUAGE SKILLS LEARNING; Professional skills and topics covered include hospitality, nursing, engineering, AI coding, computer science, social media marketing, high school exam prep, and much more.

CUSTOMIZED LEARNING PATHS AI algorithms analyze a learner's proficiency, learning style, strengths, weaknesses, and goals to create a tailor-made learning path. This ensures that the content is relevant to the individual.

A UNIQUE AI-POWERED EVALUATION SYSTEM This simulates real-life scenarios to provide the most meaningful performance assessment and proof of ability.

FROM A FINANCIAL PERSPECTIVE, THE POTENTIAL IS ENORMOUS Our platform meets specific training needs for career development across multiple industries, ensuring lucrative engagement and robust ROI. Sectors like coding and hospitality alone present giant market opportunities.

ALPHA COGNITION, INC is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative disease, such as Alzheimer’s disease and Cognitive Impairment with mild Tramautic Brain Injury (“mTBI”). The Company’s first product ZUNVEYL is approved by the U.S. Food and Drug Administration (FDA) as a cholinesterase inhibitor indicated for the treatment of mild to moderate dementia of the Alzheimer’s type in adults.

Launched in 2018, ALT5 Sigma Inc. (a wholly-owned subsidiary of ALT5 Sigma Corporation) is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Sigma Inc., through its subsidiaries, offers two main platforms to its customers: "

ALT5 Pay" and "ALT5 Prime". ALT5 Sigma Inc. processed over US$1.2 billion in cryptocurrency transactions in 2023. ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. Merchants have the option to convert to fiat currency (s) automatically or to receive their payment in digital assets.

ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named "ALT5 Pro" that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime's FIX API, as well as through Broadridge Financial Solutions' NYFIX gateway for approved customers.

Alzamend Neuro® is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease, Bipolar disorder, Major Depressive Disorder (“MDD”) and Post-Traumatic Stress Disorder (“PTSD”). Our mission is to rapidly develop and market safe and effective treatments to bring aid to the 43+ Million Americans suffering from these debilitating diseases. Our current pipeline consists of two novel therapeutic drug candidates, AL001 – a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and ALZN002 – a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer’s. Both of our product candidates are licensed from the University of South Florida Research Foundation, Inc. pursuant to royalty-bearing exclusive worldwide licenses.

CEL-SCI Corporation (NYSE American: CVM) is a biotechnology company that believes that boosting a cancer patient’s immune system before surgery, radiotherapy and chemotherapy, while it is still intact, should provide the greatest possible impact on survival.

Chromocell is a pioneer in the development of non-opioid pain treatment therapeutics with a focus on modulating NaV1.7 receptors responsible for sensing and transmitting pain in the peripheral nervous system. The Company’s programs targeting the treatment of chronic neuropathic and acute and chronic eye pain are based on its patented core molecules.

Focus Universal Inc. (NASDAQ:FCUV) is a provider of patented hardware and software design technologies for Internet of Things (IoT) and 5G. The company has developed five disruptive patented technology platforms with 28 patents and patents pending in various phases and 8 trademarks pending in various phases to solve the major problems facing hardware and software design and production within the industry today. These technologies combined to have the potential to reduce costs, product development timelines and energy usage while increasing range, speed, efficiency, and security. Focus currently trades on the Nasdaq Markets.

Greenland Technologies Holding Corp (NASDAQ: GTEC) is a leading developer and manufacturer of electric industrial vehicles and drivetrain systems for material handling vehicles.

Impact Biomedical Inc.(IBIO) discovers, confirms, and patents unique science and technologies which can be developed into new offerings in human healthcare and wellness in collaboration with external partners through licensing, co-development, joint ventures, and other relationships.

By leveraging technology and new science with strategic partnerships, we provide advances in biopharmaceuticals, over the counter direct to consumer wellness offerings, and drug discovery for the prevention, inhibition, and treatment of neurological, oncologic, and inflammatory diseases. In addition to our existing efforts, we continually search for, and evaluate, other potential new offerings to add to our portfolio.

Our business model includes partnering and potentially direct sales for commercialization and distribution.

Why Family Planning Is an Important Part of Preventive Care

When it comes to preventive care, family planning probably isn’t the first service that comes to mind, but it does directly impact health, relationships, and even plans for the future. At Radiant Health Centers, our LGBTQ+ medical clinic offers family planning services as part of an inclusive approach to care. As a leading nonprofit that has been serving the Orange County community for more than 40 years, we are dedicated to making quality healthcare something everyone can easily access.

How Family Planning Supports Health & Wellness

Family planning is an important part of preventive healthcare, as it provides patients with the information and resources needed to make purposeful choices about their reproductive health and their future. From lowering the incidence of unintended pregnancies to improving overall well-being, family planning services help people take active control of their health.

1. Encourages Individuals to Make Educated Decisions About Their Health

Family planning enables patients to take responsibility for their own health and welfare. These services provide individuals with access to the tools and information they need to take a more active role in their well-being and reproductive health. With this knowledge and access to resources, patients are better prepared to navigate their options and make plans that coordinate with their goals for the future.

2. Reduces the Risk of Unplanned Pregnancies

A primary objective of family planning is to prevent unplanned pregnancies. Patients are educated about (and can acquire) effective contraception methods. They also receive in-depth reproductive health counseling, allowing them to make decisions that work best for their specific circumstances. This support enables people to take control over their well-being and their lives.

3. Promotes Healthier Communities

Family planning helps individuals make better decisions about their reproductive health, as it encourages them to schedule routine checkups and seek early interventions when needed. Patients who use preventive reproductive healthcare services are more likely to identify concerns and receive appropriate treatments as soon as possible. This leads to better long-term outcomes, which in turn leads to stronger, healthier communities.

4. Supports Equitable Reproductive Care

Because every person is unique, the approach to family planning should reflect and honor that uniqueness. LGBTQ+ medical clinics that offer family planning services as part of preventive healthcare provide patients with guidance and resources that align with their identities, health needs and aspirations. This approach helps patients of all backgrounds feel supported and understood as they navigate important reproductive health choices.

Inclusive Family Planning Preventive Services in Orange County

Family planning is a vital part of preventive care as it encourages individuals to plan ahead and prioritize their reproductive and overall health. Radiant Health Centers provides compassionate, inclusive care designed to meet the needs of all patients. Our commitment to health equity provides every person with personalized support that respects their distinctive circumstances. Call (949) 809-5700 or request an appointment today.

Image Credit – Kmpzzz/Shutterstock.com

When Should You Consider PrEP for HIV Prevention?

If you’re at increased risk of contracting HIV, familiarizing yourself with the different prevention options can help you make the best decisions for your well-being. At Radiant Health Centers, our Orange County LGBTQ+ health clinic provides confidential PrEP services designed to help patients take control of their sexual health.

Wondering if PrEP is the right choice for you? Keep reading to learn more about this prescription medication, the benefits it provides, and when you should consider using it for HIV prevention.

An Overview of PrEP for HIV Prevention

Taking a proactive approach to HIV prevention rather than a reactive approach is the most effective way to protect your health. According to the most recent data from the Centers for Disease Control and Prevention (CDC), an estimated 31,800 new HIV infections were reported in the United States in 2024.

This data highlights the importance of preventive medications such as PrEP, which are designed to minimize the risk of infection before exposure. Understanding what PrEP is, how it works, and when it may be the right choice for you can help you make informed choices about your health.

What Is PrEP and How Does It Work?

PrEP (pre-exposure prophylaxis) is a prescription medication specially formulated to prevent HIV infection. When taken consistently, PrEP significantly reduces the risk of HIV transmission through sexual intercourse and injection drug use.

Unlike PEP (post-exposure prophylaxis) which is taken after potential exposure to HIV, PrEP is used proactively on an ongoing basis.

When Should You Consider Taking PrEP?

PrEP is a preventive medication intended for those who are HIV-negative and have a higher risk of contracting the virus. This prescription medication is most effective when taken consistently and combined with routine HIV testing.

PrEP may be worth discussing with a healthcare provider in several situations.

- Having a sexual partner who is HIV-positive.

- Being uncertain about your partner’s HIV status.

- Having multiple or new sexual partners.

- Not using condoms on a consistent basis.

- Being recently diagnosed with an STI.

- Sharing needles or syringes.

- Seeking an additional layer of HIV protection.

Since the risk of HIV varies from person to person, having a conversation with a healthcare provider is the best way to determine if PrEP is right for you.

Consult With a Healthcare Provider

Exploring available HIV prevention options can be overwhelming, especially if you don’t know where to start. When you’re considering PrEP, an experienced healthcare professional can provide the guidance and support you need to make an informed, confident decision.

At Radiant Health Centers, we are committed to improving the well-being of the Orange County community. Our LGBTQ+ medical clinic provides a wide range of confidential services designed to meet the unique needs of our patients, including HIV testing and treatment options. We’re happy to help you identify a prevention approach that aligns with your goals, and supports your overall health and well-being.

Find Out if PrEP Is Right for You

Deciding if PrEP is the right choice for you depends on your unique needs and circumstances. For more than 40 years, Radiant Health Centers has been helping patients throughout Orange County protect their health, and we’re here to answer all your questions so you can make the best decisions to support your needs. Call (949) 809-5700 or request an appointment today.

Image Credit – artem evdokimov/Shutterstock.com

Why Older LGBTQ+ Adults Need Routine Primary Care Visits

As individuals age, routine checkups play a vital role in helping patients maintain their health, well-being and independence. At Radiant Health Centers, our LGBTQ+ clinic provides inclusive primary care services in a welcoming, stigma-free environment. From preventive screenings to chronic disease management, regular care helps patients age with confidence.

Why Routine Primary Care Visits are Essential for LGBTQ+ Adults

Healthcare needs naturally evolve and often become more complex with age, making routine primary care essential. By focusing on prevention, early detection and continuous management for chronic diseases, regular doctor visits help older adults take a proactive approach to maintaining their well-being and improving their quality of life. For LGBTQ+ seniors, inclusive, affirming care ensures health needs are addressed respectfully and supports better health outcomes.

Detect Health Issues Early

Through routine primary care visits, potential health issues can be identified early-on, before they progress. Early detection allows for timely intervention, and this improves long-term health outcomes for older patients. Additionally, through regular checkups providers can monitor changes in a patient’s health, recommend appropriate screenings, and modify treatment plans as needed.

These appointments also provide LGBTQ+ seniors with the opportunity to discuss their personal health concerns that may be affecting their overall well-being. When preventive care is a priority, patients can access the resources needed to enjoy a better quality of life.

Manage Chronic Conditions

Chronic conditions such as high blood pressure, arthritis, diabetes and heart disease are common among older adults. During routine primary care visits, providers can monitor health issues and evaluate and modify treatment plans (including medications) before complications develop.

Through regular checkups, aging adults may be able to do the following.

- Manage chronic diseases more effectively.

- Detect health concerns before they worsen.

- Reduce the risk of hospitalizations.

- Maintain their independence.

Promotes Better Health Outcomes

Routine primary care addresses existing health concerns and can also help prevent future health issues. Through regular visits, older patients can access a range of preventive services designed to support long-term wellness, such as routine screenings, immunizations and nutritional support.

In addition to personal benefits, preventive medical care contributes to healthier communities, as aging adults can gain the information needed to take an active role in protecting their health. When older patients prioritize preventive care, their overall well-being improves.

Build Trust With Healthcare Providers

Routine primary care visits allow patients to develop a relationship with their primary care provider, and this can make a meaningful difference in long-term wellness. Regular visits allow providers to gain a better understanding of their patient’s health history, as well as monitor any changes in conditions as they arise. Additionally, medical providers can offer personalized guidance based on a patient’s unique needs.

It’s important for healthcare providers serving LGBTQ+ patients to build trust over time. Routine primary care visits provide patients with supportive care in a comfortable, respectful environment, helping older adults feel seen, heard and valued.

Supporting Healthy Aging Adults in Orange County

Routine primary care visits are vital for older LGBTQ+ adults. These appointments allow patients to enjoy better health outcomes, maintain their independence, and ultimately enjoy a better quality of life. For more than 40 years, Radiant Health Centers has been providing inclusive care for patients from all backgrounds. To schedule an appointment, call (949) 809-5700 or request an appointment today.

Image Credit – Goksi/Shutterstock.com

How Case Management Supports Better Health Outcomes

Successfully managing your health isn’t always as simple as scheduling a doctor’s appointment. At Radiant Health Centers, our LGBTQ+ case management services are designed to connect underrepresented members throughout the Irvine community with the essential resources needed to improve their long-term health. By taking a coordinated and personalized approach, we help patients access care and services that support their overall well-being.

How Case Management Services Improve Long-Term Health Outcomes

There are several factors that can influence an individual’s health, and these factors can make it difficult for patients to access treatment, keep up with appointments and receive long-term support. Case management services address these challenges by connecting patients with the support they require, coordinating appointments, and providing the guidance and resources needed to make better long-term health more attainable.

Makes Healthcare Easier to Navigate

Trying to navigate the healthcare system can be overwhelming for anyone, but it’s especially challenging for those who face barriers that limit their ability to access quality care. Understanding insurance policies, locating inclusive providers, scheduling appointments, and knowing where to go for support can be hard.

Case managers understand these obstacles and provide personalized support to help simplify the process. From connecting patients with affirming healthcare to explaining available services and resources, these professionals eliminate confusion, making it easier for people to get the care they need.

Improves Communication and Coordination

For patients who receive care from multiple providers, programs or organizations, clear communication and coordinated services are essential for treatment to be effective. Without coordination, vital information can be overlooked and easily lead to delays or gaps in care.

Case managers keep everyone on the same page by managing referrals, coordinating appointments, and keeping the lines of communication open between providers. This collaboration makes care more consistent and reduces unnecessary delays in treatment.

Addresses Barriers That Negatively Impact Health

Social and personal barriers can make it difficult for some people to access quality healthcare. Unreliable transportation, financial disparities, housing insecurity and limited access to social support are just some of the factors that can limit a person’s ability to access the care needed to improve their well-being.

Case managers work closely with patients to identify and navigate these obstacles. This approach improves access to care, reduces disparities and advances health equity, helping individuals from all backgrounds, including the LGBTQ+ community, achieve better health outcomes.

Encourages Preventive Care and Healthy Lifestyle Habits

Preventive care plays a critical role in long-term health outcomes by identifying potential health concerns early. Case managers coordinate regular healthcare visits and routine screenings, assist patients with following recommended care plans, and provide them with services that support their health goals.

With continued education and personalized assistance, case management programs help patients better understand why these services are crucial. They also encourage patients to take a more active role in managing their personal health and wellness and incorporating healthy habits into their lifestyle.

Connects Patients With Essential Resources

In some cases, patients require additional resources beyond traditional healthcare services to improve and maintain their health. Food assistance, housing, financial support and other social service programs can address various hardships and improve an individual’s overall well-being.

Case management programs identify patient needs and connect them to vital support systems that provide meaningful assistance. By connecting people to the appropriate resources, case managers help patients develop a foundation for healthier lives.

Promoting Healthier Futures Through Accessible Care

Case management services help patients gain access to the healthcare, resources and support they need to thrive. At Radiant Health Centers, our Orange County LGBTQ+ medical clinic is committed to ensuring that all people receive care that meets their unique circumstances in a compassionate, judgment-free environment. To learn more about the positive impact case managers have on health outcomes, contact us today. Call (949) 809-5700 or request an appointment.

Image Credit – vectorfusionart/Shutterstock.com

How PEP Fits Into a Complete HIV Prevention Plan

If you’re concerned about HIV exposure, being aware of the different prevention options is the best way to take an active role in protecting yourself and your partners. At Radiant Health Centers, our LGBTQ+ health clinic in Orange County offers confidential PEP treatment for HIV prevention, so patients can make informed decisions about their health in a compassionate, nonjudgmental environment. To find out how PEP fits into a complete HIV prevention plan, keep reading to gain invaluable information that may protect your overall well-being.

How PEP Supports HIV Prevention

If you think you’ve been exposed to HIV, knowing what steps to take and acting quickly is the best way to protect your health and put your mind at ease. PEP is an emergency HIV prevention medication that’s designed to help minimize the risk of HIV infection after potential exposure. According to the National Institutes of Health (NIH), when started within 72 hours after exposure and taken for a 28-day period, PEP is an effective way to prevent HIV.

However, as with any medication, it’s important to understand what PEP is, how it works, and how it fits into a complete HIV prevention plan, so you can make the right decision for your health.

What Is PEP and How Does It Help Prevent HIV?

PEP (or post-exposure prophylaxis) is a medication designed to help reduce the risk of HIV infection after potential exposure. Unlike PrEP (pre-exposure prophylaxis), which is used before exposure can occur, PEP is a time-sensitive emergency prevention medication intended for those who may have already been exposed.

This medication contains antiretroviral drugs that may help stop HIV from multiplying within the body and establishing an infection. PEP is prescribed by a healthcare provider and is taken over a 28-day period. To maximize effectiveness, this course of treatment should be followed exactly as directed.

PEP works best when started soon after potential exposure; the treatment window is within 72 hours. The sooner you start treatment, the better the chance that PEP will reduce the risk of an infection.

When Is PEP Recommended?

If you believe you have recently been exposed to HIV, whether through sex or any other type of contact, PEP may be recommended. A healthcare provider will evaluate your specific circumstances and determine if PEP is right for you based on key factors, including the type of exposure that occurred and your overall health.

PEP may be recommended after certain types of possible HIV exposure.

- Unprotected sex or condom failure with someone who may be HIV+

- Sexual assault or potential exposure

- Using needles or injection devices with other individuals

- Any other situation where HIV exposure may have possibly occurred

Because PEP must be started promptly and within a specific time window, it’s important to seek medical care as soon as possible. The sooner you speak with a healthcare provider, the sooner you can potentially start a PEP regimen.

The Difference Between PEP and PrEP

Though PEP and PrEP are both prescription medications that are designed to help reduce the risk of HIV infection, each is used in different circumstances. PEP is emergency prevention that is taken soon after possible HIV exposure, whereas PrEP is taken regularly prior to exposure. For more information about HIV prevention options, speak with a trusted healthcare professional.

How Testing and Treatment Support a Complete HIV Prevention Plan

While PEP may help prevent HIV after exposure, it’s just one part of a complete HIV prevention plan. Routine HIV testing is critical for gaining a clear understanding of a person’s current health status and determining the best approach to treatment.

Radiant Health Centers offers HIV testing and treatment services at our Orange County LGBTQ+ medical clinic. We offer confidential care in a welcoming environment to help patients protect their overall health and well-being.

Contact Radiant Health Centers to Create a Complete HIV Prevention Plan

PEP can play an important part in a complete HIV prevention plan. For more than 40 years, Radiant Health Centers has been a trusted healthcare provider in Orange County, offering affirming care designed to support our patients’ health and improve their quality of life. Call (949) 809-5700 or request an appointment today.

Image Credit – Pk_camera/Shutterstock.com